Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Hepatology ; (12): 29-32, 2008.
Artículo en Chino | WPRIM | ID: wpr-277616

RESUMEN

<p><b>OBJECTIVES</b>The hepatitis B virus core protein has been found in nuclei, cytoplasm, or both of hepatocytes transfected with HBV DNA. It is still unclear whether intact core particles could pass through nuclear pores and what could be the mechanism regulating the subcellular localization of the core protein. This study on the distribution of core protein in hepatocytes and its translocation has a potential advantage to learn more about the HBV life cycle.</p><p><b>METHODS</b>Dimethyl sulphoxide (DMSO, 2%), which effects hepatic differentiation, and/or 1 micro mol/L heteroaryldihydropyrimidine Bay41-4109, which interferes with the assembly of core particles, were added into HepG2.2.15 cell culture system for 4 days. The hepatitis B virus core antigen (HBcAg) and hepatitis B virus surface antigen (HBsAg) were stained with fluorescent immunocytochemistry and then observed under a confocal microscope. HBcAg in cytoplasm and nuclei were respectively extracted and analyzed using Western blot. HBV covalently closed circular DNA (cccDNA) was detected by using selective PCR method.</p><p><b>RESULTS</b>The HBcAg was mostly expressed in the cytoplasm and weak signals of cccDNA were detected in the control HepG2.2.15 cells. After DMSO treatment, the expression of HBcAg in cytoplasm was increased about 2.5-fold; the expression of HBcAg and cccDNA in nuclei also increased. With the use of Bay41-4109, the signal of HBcAg in cytoplasm decreased 2/3, but it increased in the nuclei, and cccDNA decreased in the nuclei. When the HepG2.2.15 cells were treated both with DMSO and Bay41-4109, cord-liked distribution of HBsAg was observed in the cytoplasm. HBcAg in cytoplasm was decreased 1/2 but the HBcAg in the nuclei increased about 5-fold, whereas the cccDNA was almost negative.</p><p><b>CONCLUSION</b>In HepG2.2.15 cells, the core protein is mainly assembled as a formation of core particles in the cytoplasm and they are blocked by the nuclear membrane. Bay41-4109 interferes with the assembly of core particles and the dissociated core proteins are able to enter the nuclei. DMSO promotes the nuclear entry of core protein/core particles and facilitates the formation of cccDNA.</p>


Asunto(s)
Humanos , Posicionamiento de Cromosoma , Dimetilsulfóxido , Farmacología , Células Hep G2 , Antígenos del Núcleo de la Hepatitis B , Metabolismo , Virus de la Hepatitis B , Fisiología , Metástasis de la Neoplasia , Piridinas , Farmacología , Pirimidinas , Farmacología , Proteínas del Núcleo Viral , Metabolismo , Ensamble de Virus
2.
Journal of Southern Medical University ; (12): 475-477, 2008.
Artículo en Chino | WPRIM | ID: wpr-293348

RESUMEN

<p><b>OBJECTIVE</b>To observe the effect of simvastatin on expression of CX3CR1 in the monocytes in patients with acute coronary syndrome and investigate the non-lipid mechanisms of statins against atherosclerosis.</p><p><b>METHODS</b>The expression of CX3CR1 in the monocytes was measured by quantitative real-time RT-PCR in 63 patients with acute coronary syndrome confirmed by coronary arteriography after treatment with simvastatin at 10(-7) approximately 10(-5) mol/L for 4, 8 and 12 h, respectively.</p><p><b>RESULTS</b>CX3CR1 expression in the monocytes treated with different concentrations of simvastatin was significantly lower than that in the control cells (P<0.05), and the expression in the cells treated with the agent for different time lengths was also significantly lower than that in the control cells (P<0.01).</p><p><b>CONCLUSION</b>Simvastatin can reduce CX3CR1 expression in the monocytes of the patients with acute coronary syndrome in a concentration- and time-dependent manner, so as to reduce the inflammation and stabilize the vascular plaques.</p>


Asunto(s)
Femenino , Humanos , Masculino , Síndrome Coronario Agudo , Sangre , Quimioterapia , Receptor 1 de Quimiocinas CX3C , Expresión Génica , Hipolipemiantes , Usos Terapéuticos , Monocitos , Metabolismo , Receptores de Quimiocina , Genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Simvastatina , Usos Terapéuticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA